首页 › 基金 › Euclidean Capital LLC › ORIC
Euclidean Capital LLC 对 ORIC 的持仓历史
ORIC PHARMACEUTICALS INC · 医疗保健
Euclidean Capital LLC 在 Q3 2026 的 13F 申报中披露持有 ORIC(ORIC PHARMACEUTICALS INC)989,410 股,市值约 US$13.3M,约占其申报组合的 4.12%,在其申报持仓中市值排名第 3 位。 Euclidean Capital LLC 最近 13 个申报季度中有 13 个季度披露了 ORIC 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Euclidean Capital LLC 对 ORIC 的持仓演变
Euclidean Capital LLC 于 Q3 2023 首次披露 ORIC 持仓:989,410 股(约 US$6.0M)。 该持仓在 Q1 2024 达到峰值 989,410 股,市值约 US$13.6M。 在 13 次申报中,Euclidean Capital LLC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 989,410 股、市值约 US$13.3M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 989.41K | $5.99M | 新进 |
| Q4 2023 | 989.41K | $9.10M | 持有 |
| Q1 2024 | 989.41K | $13.60M | 持有 |
| Q2 2024 | 989.41K | $7.00M | 持有 |
| Q3 2024 | 989.41K | $10.14M | 持有 |
| Q4 2024 | 989.41K | $7.98M | 持有 |
| Q1 2025 | 989.41K | $5.52M | 持有 |
| Q2 2025 | 989.41K | $10.04M | 持有 |
| Q3 2025 | 989.41K | $11.87M | 持有 |
| Q4 2025 | 989.41K | $8.09M | 持有 |
| Q1 2026 | 989.41K | $12.54M | 持有 |
| Q2 2026 | 989.41K | $10.72M | 持有 |
| Q3 2026 | 989.41K | $13.33M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ORIC 与 13F 数据
ORIC(ORIC PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 41 只申报持有 ORIC,申报仓位最大的包括:Nextech Invest Ltd. (US$96.5M), AIHC Capital Management Ltd (US$62.4M), SR ONE CAPITAL MANAGEMENT, LP (US$62.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ORIC 的基金
- Nextech Invest Ltd. 7.16M 股 · $96.48M · Q3 2026
- AIHC Capital Management Ltd 4.63M 股 · $62.38M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 4.62M 股 · $62.17M · Q3 2026
- NEA Management Company, LLC 4.12M 股 · $55.48M · Q3 2026
- Column Group LLC 3.54M 股 · $47.69M · Q3 2026
- Siren, L.L.C. 3.36M 股 · $45.23M · Q3 2026
- EcoR1 Capital, LLC 3.03M 股 · $40.79M · Q3 2026
- Venrock Adviser, LLC 2.94M 股 · $39.66M · Q3 2026
- Defilade Capital Management, L.P. 2.27M 股 · $30.61M · Q3 2026
- MPM BioImpact LLC 1.82M 股 · $24.54M · Q3 2026
- First Turn Management, LLC 1.57M 股 · $21.21M · Q3 2026
- ORBIMED ADVISORS LLC 1.56M 股 · $20.96M · Q3 2026
更多关于 Euclidean Capital LLC
常见问题
How long has Euclidean Capital LLC held ORIC?
Euclidean Capital LLC has disclosed ORIC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Euclidean Capital LLC's current position in ORIC?
As of Q3 2026, Euclidean Capital LLC holds 989.41K shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $13.33M, representing 4.12% of its reported portfolio and ranking #3.
Has Euclidean Capital LLC been buying or selling ORIC?
In the latest 13F filing (Q3 2026), Euclidean Capital LLC held unchanged its position in ORIC. The position peaked in Q1 2024 at 989.41K shares.
Which other funds hold ORIC?
Other major institutional holders of ORIC include Nextech Invest Ltd., AIHC Capital Management Ltd, SR ONE CAPITAL MANAGEMENT, LP, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.